dc.creatorSILVA, IH
dc.creatorJEREZ, CS
dc.creatorRUIZ, TA
dc.creatorSEGUEL, LM
dc.creatorCOURT, LJ
dc.creatorLABARCA, BR
dc.date.accessioned2024-01-10T13:49:46Z
dc.date.available2024-01-10T13:49:46Z
dc.date.created2024-01-10T13:49:46Z
dc.date.issued1994
dc.identifier0300-5062
dc.identifierMEDLINE:7817846
dc.identifierhttps://repositorio.uc.cl/handle/11534/79479
dc.identifierWOS:A1994QA19400002
dc.description.abstractDrug-naive schizophrenic patients lacked abnormal involuntary movements. Chronic neuroleptic treatment was associated in 4% of the cases with Tardive Dyskinesia (TD). These findings suggest that schizophrenia, at least in its early stages, is not contributing to the appearance of Tardive Dyskinesia, and also underscore the importance of using the lowest effective neuroleptico dose to reduce the risk of that syndrome.
dc.languagees
dc.publisherEDITORIAL GARSI
dc.rightsregistro bibliográfico
dc.subjectTARDIVE DYSKINESIA
dc.subjectSCHIZOPHRENIA
dc.subjectNEUROLEPTICS
dc.subjectHALOPERIDOL
dc.subjectDEPOT NEUROLEPTICS
dc.subjectCHLORPROMAZINE
dc.subjectTARDIVE-DYSKINESIA
dc.subjectPREVALENCE
dc.subjectEPIDEMIOLOGY
dc.subjectASSOCIATION
dc.titleLACK OF INVOLUNTARY ABNORMAL MOVEMENTS IN UNTREATED SCHIZOPHRENIC-PATIENTS
dc.typeartículo


Este ítem pertenece a la siguiente institución